# Morphogen-IX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/morphogen-ix

- Industry: Pharmaceuticals
- Headquarters: Cambridge, UK
- Website: www.morphogen-ix.com
- Total disclosed funding: $26M
- Latest round: Series B (Dec 19, 2018)
- Investors on record: 4

## About

Established in 2015 and based in Cambridge, UK, Morphogen-IX Ltd is a biotech company that develops a drug treatment for pulmonary arterial hypertension.

## Funding rounds

- Series B, Dec 19, 2018, $23M — Cambridge Enterprise, Cambridge Innovation Capital, Medicxi
- Series A, Nov 3, 2015, $2.3M — Index Ventures, Cambridge Enterprise, Cambridge Innovation Capital

## Investors

- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Series A
- Cambridge Enterprise — Series A, Series B
- Cambridge Innovation Capital (https://capitalatlas.ai/funds/cambridge-innovation-capital) — Series A, Series B
- Medicxi (https://capitalatlas.ai/funds/medicxi) — Series B